These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

915 related items for PubMed ID: 15545572

  • 1. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Kroon BB.
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [Abstract] [Full Text] [Related]

  • 2. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB.
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure.
    Grünhagen DJ, van Etten B, Brunstein F, Graveland WJ, van Geel AN, de Wilt JH, Eggermont AM.
    Ann Surg Oncol; 2005 Aug; 12(8):609-15. PubMed ID: 15968498
    [Abstract] [Full Text] [Related]

  • 6. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM, Vrouenraets BC, van Geel BN, Eggermont AM, Klaase JM, Nieweg OE, Kroon BB.
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [Abstract] [Full Text] [Related]

  • 7. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB, Vrouenraets BC, van Geel AN, Nieweg OE, Noorda EM, Eggermont AM, Kroon BB.
    J Surg Oncol; 2005 Aug 01; 91(2):107-11. PubMed ID: 16028280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
    Grunhagen DJ, de Wilt JH, Graveland WJ, Verhoef C, van Geel AN, Eggermont AM.
    Cancer; 2006 Apr 15; 106(8):1776-84. PubMed ID: 16541435
    [Abstract] [Full Text] [Related]

  • 11. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM, Takkenberg B, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Hart GA, Kroon BB.
    Ann Surg Oncol; 2004 May 15; 11(5):491-9. PubMed ID: 15078633
    [Abstract] [Full Text] [Related]

  • 12. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM.
    Ann Surg Oncol; 2007 Jan 15; 14(1):230-8. PubMed ID: 17066234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
    Cherix S, Speiser M, Matter M, Raffoul W, Liénard D, Theumann N, Mouhsine E, Mirimanoff RO, Leyvraz S, Lejeune FJ, Leyvraz PF.
    J Surg Oncol; 2008 Sep 01; 98(3):148-55. PubMed ID: 18668638
    [Abstract] [Full Text] [Related]

  • 18. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD, Sussman JJ, Kraybill WG, Kane JM, Alexander HR, Lee JE, Mansfield PF, Pingpank JF, Winchester DJ, White RL, Chadaram V, Herndon JE, Fraker DL, Tyler DS, American College of Surgeons Oncology Group Trial Z0020.
    J Clin Oncol; 2006 Sep 01; 24(25):4196-201. PubMed ID: 16943537
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology.
    Sanki A, Kam PC, Thompson JF.
    Ann Surg; 2007 Apr 01; 245(4):591-6. PubMed ID: 17414608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.